We were also able to show that MALAT1 is aberrantly expressed in TMAs of three cancer groups (colorectal, breast, and pancreatic), suggesting that lncRNA MALAT1 is associated with multiple cancers and its use as a therapeutic target should be investigated further. This evidence concerns the gene MALAT1 and cancer.